La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Abbott Laboratories Gestione
Gestione criteri di controllo 3/4
Abbott Laboratories' Il CEO è Robert Ford, nominato in Oct2018, e ha un mandato di 5.83 anni. la retribuzione annua totale è $ 23.27M, composta da 6.4% di stipendio e 93.6% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.024% delle azioni della società, per un valore di $ 46.33M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.6 anni e 5.5 anni.
Informazioni chiave
Robert Ford
Amministratore delegato
US$23.3m
Compenso totale
| Percentuale dello stipendio del CEO | 6.4% |
| Mandato del CEO | 5.9yrs |
| Proprietà del CEO | 0.02% |
| Durata media del management | 5.7yrs |
| Durata media del Consiglio di amministrazione | 5.6yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Why We're Not Concerned About Abbott Laboratories' (NYSE:ABT) Share Price
Sep 27
Abbott Laboratories: Cardiovascular Disease Has Been A Tailwind, But Things Could Change
Sep 11A Look At The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)
Aug 16Abbott Laboratories: Driving Value By Scaling Innovations
Aug 13Abbott Laboratories: A Strong Healthcare Stock For Long-Term Dividend Growth Investors
Aug 05Abbott Laboratories: When Double-Digit Device Growth Apparently Isn't Enough
Jul 13These 4 Measures Indicate That Abbott Laboratories (NYSE:ABT) Is Using Debt Reasonably Well
Jul 01Abbott Laboratories (NYSE:ABT) Is Doing The Right Things To Multiply Its Share Price
Jun 18Investors Still Waiting For A Pull Back In Abbott Laboratories (NYSE:ABT)
Jun 04Abbott Laboratories: Why I Agree With Wall Street On This One
Jun 04Abbott Laboratories: Buying More Of This Top-Notch Dividend Growth Stock
May 18Abbott Laboratories: Organic Growth Will Be Key To Q1 Earnings
Apr 17Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)
Apr 15Abbott Laboratories: Buy This World-Class Dividend Growth Stock Now
Mar 21Abbott Laboratories (NYSE:ABT) Might Have The Makings Of A Multi-Bagger
Mar 19Here's Why Abbott Laboratories (NYSE:ABT) Can Manage Its Debt Responsibly
Mar 06Abbott Labs' Reversal Is Here - CGM Tailwinds In 2024
Feb 27Abbott Laboratories' (NYSE:ABT) Shares May Have Run Too Fast Too Soon
Feb 08The King Is Back: Abbott Laboratories' Path To >11% Annual Returns
Jan 29The Abbott Laboratories (NYSE:ABT) Full-Year Results Are Out And Analysts Have Published New Forecasts
Jan 26Abbott Laboratories: Another Healthy Dividend Hike From This Dividend King
Dec 28Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)
Dec 27Abbott Laboratories: A 'Must-Have' In A Defensive Dividend Growth Portfolio
Dec 03Is Abbott Laboratories (NYSE:ABT) Using Too Much Debt?
Nov 29Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$6b |
| Mar 31 2024 | n/a | n/a | US$6b |
| Dec 31 2023 | US$23m | US$2m | US$6b |
| Sep 30 2023 | n/a | n/a | US$5b |
| Jun 30 2023 | n/a | n/a | US$5b |
| Mar 31 2023 | n/a | n/a | US$6b |
| Dec 31 2022 | US$22m | US$2m | US$7b |
| Sep 30 2022 | n/a | n/a | US$8b |
| Jun 30 2022 | n/a | n/a | US$9b |
| Mar 31 2022 | n/a | n/a | US$8b |
| Dec 31 2021 | US$25m | US$1m | US$7b |
| Sep 30 2021 | n/a | n/a | US$7b |
| Jun 30 2021 | n/a | n/a | US$6b |
| Mar 31 2021 | n/a | n/a | US$6b |
| Dec 31 2020 | US$20m | US$1m | US$4b |
| Sep 30 2020 | n/a | n/a | US$3b |
| Jun 30 2020 | n/a | n/a | US$3b |
| Mar 31 2020 | n/a | n/a | US$4b |
| Dec 31 2019 | US$12m | US$1m | US$4b |
| Sep 30 2019 | n/a | n/a | US$3b |
| Jun 30 2019 | n/a | n/a | US$3b |
| Mar 31 2019 | n/a | n/a | US$3b |
| Dec 31 2018 | US$8m | US$784k | US$2b |
| Sep 30 2018 | n/a | n/a | US$802m |
| Jun 30 2018 | n/a | n/a | US$812m |
| Mar 31 2018 | n/a | n/a | US$365m |
| Dec 31 2017 | US$5m | US$675k | US$344m |
Compensazione vs Mercato: La retribuzione totale di Robert ($USD 23.27M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 13.21M ).
Compensazione vs guadagni: La retribuzione di Robert è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Robert Ford (50 yo)
5.9yrs
Mandato
US$23,268,171
Compensazione
Mr. Robert B. Ford has been the Chief Executive Officer of Abbott Laboratories since March 31, 2020 and also serves as its Chairman of the Board since December 10, 2021. He has been President at Abbott Lab...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Chairman of the Board | 5.9yrs | US$23.27m | 0.024% $ 46.9m | |
| CFO & Executive VP of Finance | less than a year | US$3.32m | 0.0023% $ 4.4m | |
| Executive VP | 11.7yrs | US$7.42m | 0.011% $ 20.8m | |
| Executive VP and Group President of Established Pharmaceuticals & Nutritional Products | 10yrs | US$5.93m | 0.0072% $ 14.1m | |
| Executive VP & Group President of Medical Devices | 5.7yrs | US$5.50m | 0.0035% $ 6.9m | |
| Senior VP of Business & Technology Services and Chief Information Officer | less than a year | Nessun dato | Nessun dato | |
| Vice President of Investor Relations. | no data | Nessun dato | Nessun dato | |
| VP and Chief Ethics & Compliance Officer | no data | Nessun dato | Nessun dato | |
| Vice President of Public Affairs & Corporate Marketing | no data | Nessun dato | Nessun dato | |
| Senior Vice President of Commercial Operations | 1.7yrs | Nessun dato | Nessun dato | |
| Executive Vice President of Human Resources | 5.1yrs | Nessun dato | 0.0059% $ 11.5m | |
| Executive Vice President of Diabetes Care | 9.3yrs | Nessun dato | 0.0041% $ 8.1m |
5.7yrs
Durata media
54yo
Età media
Gestione esperta: Il team dirigenziale di ABT è esperto e expertise (durata media dell'incarico 5.6 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Chairman of the Board | 4.8yrs | US$23.27m | 0.024% $ 46.9m | |
| Independent Director | 7.6yrs | US$349.29k | 0.39% $ 754.4m | |
| Independent Director | 7.7yrs | US$341.96k | 0.00020% $ 391.2k | |
| Lead Independent Director | 12.8yrs | US$405.96k | 0.00027% $ 528.2k | |
| Independent Director | 3.4yrs | US$337.96k | 0% $ 0 | |
| Independent Director | 15.9yrs | US$441.44k | 0% $ 0 | |
| Independent Director | 1.4yrs | US$283.96k | 0% $ 0 | |
| Independent Director | 6.3yrs | US$331.96k | 0.00018% $ 352.1k | |
| Independent Director | 12.8yrs | US$362.60k | 0.00015% $ 293.4k | |
| Independent Director | 2yrs | US$354.96k | 0% $ 0 | |
| Independent Director | 5yrs | US$331.19k | 0% $ 0 | |
| Independent Director | 3.1yrs | US$356.96k | 0% $ 0 |
5.6yrs
Durata media
62yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di ABT sono considerati esperti (durata media dell'incarico 5.5 anni).